An interim report on implementing national pharmacare in Canada that highlights the importance of cost savings and access to medicines has been welcomed by local off-patent industry body the CGPA.

Australia’s GBMA industry association will seek to promote biosimilars through a dedicated ‘Biosimilar Week’ in late April and early May this year, running as part of a three-year education program being pursued by the association and industry stakeholders.

Supply issues highlighted by UK pharmacists drove up local prices for generic metoprolol in February, according to the latest figures from market researcher WaveData.

Six value added medicines case studies across six European countries are featured in the latest IQVIA report for Medicines for Europe. Each of them, according to the association’s sector chair Arun Narayan, helps point to a way forward for value added medicines in Europe.

As candesartan tablets saw their average UK trade prices leap by as much as five times in January, temazepam tablets plummeted by almost two-thirds, according to the latest figures from market researcher WaveData.

French authorities must pull back from their reliance on price cuts as a source of savings and introduce a raft of measures to boost the use of generics against a backdrop of subdued growth, according to local off-patent industry association Gemme.